Aprea Therapeutics, Inc.
Doylestown, PA
- UEI
- P4B7EG3NM1T6
- CAGE
- 9DVZ8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3805 Old Easton Rd, Doylestown, PA 18902, USA
- Website
- aprea.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous… | National Cancer Institute (NIH) | $2,858,776 |
Quick answers
Is Aprea Therapeutics, Inc. registered in SAM.gov?
Yes. Aprea Therapeutics, Inc.'s SAM.gov registration is active through September 19, 2027.
What is Aprea Therapeutics, Inc.'s most recent federal award?
Aprea Therapeutics, Inc.'s most recent federal grant award is Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous… (R44CA278078), from National Cancer Institute (NIH), on February 10, 2023.
On GovTribe
See Aprea Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors